Regeneron Pharmaceuticals News Timeline

Regeneron Pharmaceuticals Inc -- USA Stock  

USD 371.53  0.25  0.0673%

This is yet another view into Regeneron Pharmaceuticals filtered headlines to help investors concentrate on Regeneron Pharmaceuticals Inc noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Regeneron Pharmaceuticals headlines in addition to utilizing other more conventional financial analysis modules. Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis
news
December 28, 2017
Stock Alert Regeneron Pharmaceuticals Inc Price Volatility Hits A Depressed Level at news.cmlviz.com 
View Story
news
January 19, 2018
Watch-list Mover Regeneron Pharmaceuticals, Inc. stock price settles ... at www.isstories.com 
View Story
news
October 30, 2017
Analyzing Profit-Making Efficiency Boyd Gaming Corporation , Quintiles ... at www.usacommercedaily.com 
View Story
news
January 18, 2018
Reigning shares of the market today Vertex Pharmaceuticals Incorporated ... at news4j.com 
View Story
Macroaxis News
December 28, 2017
Exercise or conversion by Paul Silva of 1289 shares of Vertex Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
January 19, 2018
Could Hospitals Making Generic Assets Impact Teva Pharmaceutical Industries ... at www.smarteranalyst.com 
View Story
Market Realist News
January 19, 2018
Will Abbott 4Q17 Sales Results Exceed Analyst Expectations at marketrealist.com 
View Story
Macroaxis News
December 26, 2017
Acquisition by Sally Blount of 3437 shares of Abbott Laboratories subject to Rule 16b-3 at MacroaxisInsider 
View Story
Macroaxis News
January 18, 2018
Sale by Robert Stewart of 8000 shares of Allergan plc at MacroaxisInsider 
View Story
Macroaxis News
January 18, 2018
Exercise or conversion by Ronald Hutton of 150 shares of Bio Rad subject to Rule 16b-3 at MacroaxisInsider 
View Story